Where to buy Semax has five plausible answers and they are not five prices for one item. They are five businesses selling five different things under a shared name, and until you separate them, every comparison you make is arithmetic performed on nothing.
Key takeaways
- Research-peptide suppliers are the only channel that reliably hands over a labelled, lot-numbered vial with a certificate attached to that lot.
- Nootropic retailers sell a nasal spray. It is a different product in a different format, usually priced per bottle with no total peptide content stated, so it cannot be compared to a 10 mg vial on price at all.
- The compounding pharmacy row is empty. Semax was nominated, was placed in category 2 under FDA's interim policies, and the nomination was withdrawn, so there is no ordinary prescription path.
- Overseas bulk is the cheapest per milligram and gives up the two things that decide this purchase: batch-specific testing and any recourse when a parcel is seized.
- FDA's concern is immunogenicity from aggregation and peptide-related impurities. That is a manufacturing and handling question, which is exactly what changes between channels.
Here is the reference point the other four channels get measured against, so the numbers are visible while you read rather than saved for a conclusion.
The vendor we point lifters to
Semax from Ascension Peptides
Independently assayed material, dispatched from the US. The vial drops by half with the code below.
The published certificate for batch 30-05260628 carries a kinetic chromogenic LAL endotoxin test to USP Chapter 85, reporting under 0.20 EU/mL against a 0.5 EU/mL limit, plus a sterility screen. Buying 3, 5 or 10 takes 3%, 5% or 10% off the list price.
- Two independent lab reports per batch
- Free delivery above $250
- Same-day dispatch on orders before 2pm CST
Research material, laboratory use only, not for human consumption. Affiliate links: we may earn a commission at no extra cost to you. Pricing verified August 21, 2026.
Where to buy Semax: the five channels side by side
| Channel | What arrives | Where the risk sits | Typical cost |
|---|---|---|---|
| Domestic research supplier | Lyophilised 10 mg vial, lot number, batch certificate, research-use labelling | Testing scope varies by lot, and there is no clinical oversight of any kind | Roughly $3 to $6 per mg before codes |
| Nootropic retailer, nasal spray | A consumer spray in a pump bottle, strength often quoted per spray | Total peptide content frequently unstated, so there is no unit to compare | Priced per bottle, rarely per mg |
| Compounding pharmacy | Almost always nothing, because the nomination was withdrawn | A pharmacy offering it anyway is the signal, not the solution | Not meaningfully priced |
| Overseas bulk seller | Unlabelled or minimally labelled powder, generic certificate | Customs, cold chain, no lot traceability, no recourse | Lowest per mg by a wide margin |
| Reseller or group buy | Repackaged material of unknown origin | No lot, no certificate, no business that can be contacted | Cheap, then irrelevant |
Two rows do most of the damage to a naive comparison. The spray row quietly makes price meaningless, and the pharmacy row is the one readers are most surprised to find empty.
The spray row, and why it breaks every price comparison
Search for a Semax nasal spray and the results change character completely. Nootropic retailers sell a ready-made solution in a pump bottle, while research suppliers sell lyophilised powder in a sealed vial. Those are not two offers on one product.
The problem is the unit. A vial is sold by mass, and 10 mg means 10 mg. A spray is sold by volume, usually with a percentage concentration on the label, sometimes with a strength quoted per actuation, and often with no total peptide content stated anywhere on the page. Without a milligram figure on both sides there is no shared denominator, so a bottle price and a vial price sit in different currencies.
Format also changes what testing is worth asking about. A solution sitting at room temperature in a pump bottle raises preservation and microbial questions that a sealed lyophilised powder does not, and it raises them for the seller rather than the buyer. We worked through the same trap on the neighbouring compound in buying Selank as a nasal spray, where the arithmetic falls apart in exactly the same place.
For the record, and because readers ask: the vendor above sells the vial, not a spray. That is a statement about what is in stock, not a claim about which format is better for anything.
Why the pharmacy row is empty
This is the row people arrive assuming exists. It does not, and the history is worth stating precisely because most pages get it wrong in one direction or the other.
Semax was nominated as a bulk drug substance for use in compounding. It was placed in category 2 under FDA's interim policies while the agency evaluated it, and the nomination was then withdrawn by the nominator. It now appears on FDA's safety risks page, content current as of 04/22/2026, in the section headed "Bulk drug substances nominated but withdrawn", listed as "Semax (heptapeptide)". It does not appear on FDA's 503A bulk substances page, content current as of 05/14/2026, in any category.
So "Semax was in category 2" is stale, "Semax is category 2" is wrong, and "Semax is on no current category list" is the accurate version. There is also no FDA approval for it for any indication. The Russian registration covering cognitive and stroke indications is real, and it is a foreign registration rather than something a US pharmacy can dispense against.
The practical consequence is short. There is no prescriber to ask, so the pharmacy channel is not a harder route than the others. It is not a route.
What the research-supplier row actually contains
This is the channel that works, and it works because the product is a defined object with paperwork attached to it.
Semax is a synthetic heptapeptide, seven residues, Met-Glu-His-Phe-Pro-Gly-Pro, built from the ACTH(4-7) fragment with a proline-glycine-proline tail added to slow enzymatic breakdown. PubChem CID 9811102 gives the formula as C37H51N9O10S and the molecular weight as 813.9, which means every certificate has a public reference to be checked against.
The listing above publishes two reports from two laboratories, and the gap between them is the most useful thing in this article. The Kovera Labs combined certificate for batch 30-05260628, certified 06/15/2026, covers purity at 99.886% against a greater than 98% specification, identity by LC-MS, net content of 11.23 mg against a 10 mg label, a bacterial endotoxin result below 0.20 EU/mL against a 0.5 EU/mL acceptance limit by kinetic chromogenic LAL to USP Chapter 85, a rapid sterility screen returning no growth, and elemental impurities by ICP-MS with lead, arsenic, cadmium and mercury all under limit.
The earlier MZ Biolabs certificate for lot 30-01260229, analysed 2026-02-09, covers purity at 99.75% by HPLC-UV with the chromatogram printed, identity by HPLC-MS at 813.35 Da expected against 813.41 Da measured, and quantity at 10.12 mg per vial. It carries no endotoxin result and no sterility screen.
Same product, same store, two documentation standards four months apart. The conclusion is not that one lab is better than the other. It is that "does this vendor test for endotoxin" is the wrong question and "what does the certificate for the lot you are shipping cover" is the right one.
Why the cheap rows score badly on risk
FDA's documented concern with this compound is narrow and specific. Compounded drugs containing semax (heptapeptide), the agency writes, "may pose risk for immunogenicity for certain routes of administration due to the potential for aggregation and peptide-related impurities", and it adds that it has no, or limited, safety-related information for proposed routes of administration.
Read that as a manufacturing statement rather than a pharmacological one. Aggregation and peptide-related impurities come from how material was synthesised, purified, filled, shipped and stored. Those are precisely the variables that differ between an audited facility with cold dispatch and a padded envelope that crossed two borders. Endotoxin is the measurable end of it, it persists after the bacteria that produced it are gone, and it does not show up in a purity number.
That is why the overseas and reseller rows lose on risk even when the powder in them is genuine. The peptide can be real and the handling still unknown. The same reasoning, applied where the documented failure was a different one, is in where to buy NAD+, where the problem was food-grade material reaching preparations that should have been sterile.
Where can I buy Semax, stripped of the channels that do not deliver
Once the spray is set aside as a different product, the pharmacy row as an empty one, and the overseas rows as a trade of price for traceability, the honest answer is that a domestic research supplier with lot-specific certificates is the only channel that consistently produces a labelled vial, a document naming its batch, and a price that can be stated per milligram.
None of that is an argument that a lifter should buy it. Semax is sold against mental fatigue and flat drive rather than muscle, which is at least honest positioning, and the evidence behind it is thin where a Western reader can check it. A PubMed search for semax returns mostly rodent work and small Russian-language reports, and the registered trial record is the check on any seller implying more. If drive has gone flat in week six of a block, the causes with real human evidence behind them are duller and cheaper, and we cover the main one in sleep, cortisol and myostatin.
Frequently asked questions
Where can I buy Semax in the United States?
In practice, from a domestic research-peptide supplier that publishes a batch certificate tied to the lot number on the vial. There is no ordinary compounding pharmacy route because the bulk nomination was withdrawn, and there is no FDA approval for Semax for any indication.
Is the nasal spray sold by nootropic retailers the same thing?
It is the same peptide in a different product. The spray is a solution in a pump bottle, the vial is lyophilised powder, and spray listings often state strength per actuation or not at all. Without a total milligram figure on the bottle there is nothing to compare against a vial price.
Why is overseas Semax so much cheaper per milligram?
Because most of the domestic price is not the peptide. It is batch-specific third-party testing, domestic dispatch, stock held in conditions someone is accountable for, and a business that can be contacted. Overseas bulk removes all four, plus any recourse if the parcel is seized or never arrives.
Can a doctor prescribe Semax if I ask?
There is no FDA-approved Semax product to prescribe, and no current 503A category listing to compound against, so a US prescriber has nothing to write. FDA lists it under bulk substances nominated but withdrawn. Anyone offering a prescription route is worth questioning closely.
What single question sorts a good seller from a bad one?
Ask which lot they will ship and what its certificate covers. A good answer is a lot number and a report including identity, purity against a stated specification, and a bacterial endotoxin figure. A bad answer is brand-level reassurance, a testimonial, or a certificate with no lot printed on it.
Sources
- Certain Bulk Drug Substances for Use in Compounding that May Present Significant Safety Risks, FDA
- Bulk Drug Substances Used in Compounding Under Section 503A, FDA
- Semax, PubChem CID 9811102
- Certificate of analysis, Semax batch 30-05260628, Kovera Labs
- Certificate of analysis, Semax lot 30-01260229, MZ Biolabs
- Registered studies of Semax, ClinicalTrials.gov
This article is for educational purposes only and is not medical advice. Semax holds no FDA approval for any indication, has no US prescription route, and material sold by research suppliers is labelled for laboratory use only and not for human consumption. A foreign registration is not an FDA approval or evidence of efficacy by Western regulatory standards. Speak with a qualified healthcare professional before making any decision involving peptides, injections or unapproved compounds.